news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

original title:

the city's 33 a-share listed companies achieved profits of 3.996 billion yuan in the first half of the year

this newspaper(reporteryan hui) as of the evening of august 31, the semi-annual reports of 33 a-share listed companies in our city have all been disclosed. in the first half of this year, the total revenue of 33 a-share listed companies in our city was 73.057 billion yuan, and the total net profit was 3.996 billion yuan.

in the first half of this year, among the 33 a-share listed companies in our city, 23 companies achieved positive year-on-year growth in operating income, and the operating income of the other 10 companies declined to varying degrees compared with the same period last year. qixiang tengda ranked first in revenue with 12.729 billion yuan, becoming the only listed company with revenue of over 10 billion yuan in the first half of this year. however, compared with the same period last year, operating income fell by 7.66%. bohui paper ranked second in the revenue ranking, with revenue of 9.262 billion yuan in the first half of the year, a year-on-year increase of 6.99%; xinhua medical ranked third with 5.187 billion yuan, a year-on-year increase of 2.24%. the bottom three in terms of revenue were zhuochuang information, yahua electronics, and luxin venture capital.

in terms of net profit, the top three companies are all in the medical device industry. intech medical ranked first with 587 million yuan, xinhua medical ranked second with 484 million yuan, and shandong yaobo ranked third with 475 million yuan.

the 33 a-share listed companies in our city involve many industries such as chemicals, new materials, medical devices, biomedicine, intelligent equipment, glass and ceramics, cultural media, textiles and clothing, internet services, agriculture, forestry, animal husbandry and fishery, etc. qixiang tengda, shandong yaobo, freda, jinling mining, luxin venture capital, xinhua medical, and xinhua pharmaceutical are state-owned enterprises, luyang energy conservation is a sino-foreign joint venture, and the rest are private enterprises.